The roles of adenosine signaling in systemic lupus erythematosus

• Published in: Heliyon
• Main Authors: Ke Dong, Xia-nan Wu, Ying-qi Liu, Lan Yang, Chong Liu, Hui-ping Wang, Zhao-wei Gao
• Format: Article
• Language: English
• Published: Elsevier 2024-05-01
• Subjects: CD39; CD73; Adenosine deaminase; Adenosine; Systemic lupus erythematosus
• Online Access: http://www.sciencedirect.com/science/article/pii/S2405844024058791

Systemic lupus erythematosus (SLE) is a complex autoimmune disease with multiple etiological factors. Immune disorder contributes to SLE development and is an important clinical manifestation of SLE patients. Immune dysfunction is characterized by abnormal of B cells, T cells, monocyte-macrophages and dendritic cells (DCs), in both quantity and quality. Adenosine is a critical factor for human immune homeostasis, which acts as an immunosuppressive signal and can prevent the hyperactivity of human immune system. Adenosine levels are significant decreased in serum from SLE patients. Adenosine level is regulated by the CD39, CD73 and adenosine deaminase (ADA). CD39/CD73/ADA catalyzed the cascade enzymatic reaction, which contained the adenosine generation and degradation. Adenosine affects the function of various immune cells via bind to the adenosine receptors, which are expressed on the cell surface. This review aims to export the changes of immune cells and adenosine signal pathway in SLE, as well as the effect of adenosine signal pathway in SLE development.